Skip to main content Skip to footer
Donate
Michigan

Michigan

State Facts

1,146

Deaths, or 65.9% of all overdose deaths in the year ending April 2025 involved opioids.¹

2.4 Million

Claims, or 4.36% of all Medicare Part D claims were for opioids in 2023 – an average of 52 per prescriber.²

47.9

Opioid Prescriptions were written for every 100 persons in Michigan in 2023.³

$161.9 Billion

the estimated total societal cost of opioid use disorder (OUD) in Michigan in 2024.⁴

Download FactSheet

Opioid Settlement Funds

$1,605,250,645.25
State Spending Recommendation

Prevent inappropriate prescribing of drugs with addictive potential.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Cosponsors (119th)

Rep. Shri Thanedar (D-MI-13)

Rep. Shri Thanedar (D-MI-13)

Rep. Tom Barrett (R-MI-7)

Rep. Tom Barrett (R-MI-7)

Rep. Jack Bergman (R-MI-01)

Rep. Jack Bergman (R-MI-01)

Rep. Shri Thanedar (D-MI-13)

Rep. Shri Thanedar (D-MI-13)

2025 Introduced Relevant Legislation

Senate Bill 551

SB 551 prohibits Michigan Medicaid from disadvantaging or discouraging coverage of non-opioid prescription drugs compared to opioids or narcotics for the treatment or management of pain, including through stricter utilization controls such as prior authorization or step therapy. The legislation also requires that newly FDA-approved non-opioid pain drugs be added to the Michigan Medicaid preferred drug list within 90 days.

Introduced
09/17/2025
Plan Impact
Medicaid
Learn More

Senate Bill 552

SB 552 prohibits private health insurers from disadvantaging or discouraging coverage of non-opioid prescription drugs compared to opioids or narcotics for the treatment or management of pain, including through stricter utilization controls such as prior authorization or step therapy. The legislation also mandates timely formulary inclusion of non-opioid pain drugs within 90 days of FDA approval.

Introduced
09/17/2025
Plan Impact
Private
Learn More

Voices Letters

Support for SB 551 & SB 552

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2025). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Centers for Disease Control and Prevention (2025). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Avalere Health (2025). The cost of addiction: Opioid use disorder in the United States. https://advisory.avalerehealth.com/wp-content/uploads/2025/05/Avalere-Health-White-Paper_The-cost-of-opioid-addiction_OUD-in-the-United-States.pdf